Carmelo Cerra1, Michael A Harris1, Christine J Hawkins2. 1. Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia. 2. Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia c.hawkins@latrobe.edu.au.
Abstract
BACKGROUND/AIM: Ewing sarcomas most commonly arise in the bones, but can also manifest as extraskeletal tumours in soft tissues. Metastases from extraskeletal Ewing sarcomas occur in more diverse anatomical sites than skeletal tumours, and have poorer survival rates. Few animal models replicate the extraskeletal form of Ewing sarcoma, and those that have been developed do not reflect the widespread metastatic spread of these cancers. MATERIALS AND METHODS: Luciferase-expressing Ewing sarcoma cells derived from a muscle tumour were intramuscularly or intravenously injected into nude mice. RESULTS: Both models achieved metastatic spread to numerous sites including the lungs, liver, kidneys, and brain. We characterized the cellular composition of primary and metastatic tumours, observing a greater level of immune cell infiltration in metastases compared to primary intramuscular tumours. CONCLUSION: These pre-clinical models will hopefully facilitate the evaluation of novel therapies and contribute to better understanding the disease progression of metastatic extraskeletal Ewing sarcoma.
BACKGROUND/AIM: Ewing sarcomas most commonly arise in the bones, but can also manifest as extraskeletal tumours in soft tissues. Metastases from extraskeletal Ewing sarcomas occur in more diverse anatomical sites than skeletal tumours, and have poorer survival rates. Few animal models replicate the extraskeletal form of Ewing sarcoma, and those that have been developed do not reflect the widespread metastatic spread of these cancers. MATERIALS AND METHODS: Luciferase-expressing Ewing sarcoma cells derived from a muscle tumour were intramuscularly or intravenously injected into nude mice. RESULTS: Both models achieved metastatic spread to numerous sites including the lungs, liver, kidneys, and brain. We characterized the cellular composition of primary and metastatic tumours, observing a greater level of immune cell infiltration in metastases compared to primary intramuscular tumours. CONCLUSION: These pre-clinical models will hopefully facilitate the evaluation of novel therapies and contribute to better understanding the disease progression of metastatic extraskeletal Ewing sarcoma.
Authors: Mamie Yu; Suresh K Selvaraj; May M Y Liang-Chu; Sahar Aghajani; Matthew Busse; Jean Yuan; Genee Lee; Franklin Peale; Christiaan Klijn; Richard Bourgon; Joshua S Kaminker; Richard M Neve Journal: Nature Date: 2015-04-16 Impact factor: 49.962
Authors: Mark A Applebaum; Jennifer Worch; Katherine K Matthay; Robert Goldsby; John Neuhaus; Daniel C West; Steven G Dubois Journal: Cancer Date: 2011-01-10 Impact factor: 6.860
Authors: Richard B Womer; Daniel C West; Mark D Krailo; Paul S Dickman; Bruce R Pawel; Holcombe E Grier; Karen Marcus; Scott Sailer; John H Healey; John P Dormans; Aaron R Weiss Journal: J Clin Oncol Date: 2012-10-22 Impact factor: 44.544
Authors: L D Shultz; P A Schweitzer; S W Christianson; B Gott; I B Schweitzer; B Tennent; S McKenna; L Mobraaten; T V Rajan; D L Greiner Journal: J Immunol Date: 1995-01-01 Impact factor: 5.422
Authors: Kyle A Dyson; Brian D Stover; Adam Grippin; Hector R Mendez-Gomez; Joanne Lagmay; Duane A Mitchell; Elias J Sayour Journal: J Hematol Oncol Date: 2019-07-16 Impact factor: 17.388
Authors: Britta Vormoor; Henrike K Knizia; Michael A Batey; Gilberto S Almeida; Ian Wilson; Petra Dildey; Abhishek Sharma; Helen Blair; I Geoff Hide; Olaf Heidenreich; Josef Vormoor; Ross J Maxwell; Chris M Bacon Journal: PLoS One Date: 2014-01-07 Impact factor: 3.240